UAV for Medical Equipment Distribution

This Final Design Review report documents the senior project participating in the Vertical Flight Society’s 38th Annual Student Design Competition sponsored by The Boeing Company. The goal of this project and competition is to develop an unmanned vertical lift for medical equipment distribution capable of safely delivering a 50 kg payload over distances up to 200 km. This system must be autonomous and have a backup plan to land if any part of the system malfunctions. We discuss the research and justification that drove the selection of the aircraft configuration, a winged quadcopter with a rear propeller. Furthermore, we document our reasoning and analysis for sizing and shaping of the rotors, propeller, and wings, selecting a hybrid-electric turbogenerator for the powerplant, designing the payload release mechanism, and sizing and shaping of the semi-monocoque structure. We provide analysis that numerically verifies our UAV’s ability to meet the requirements for payload capacity, range, mission time, and geometric envelope

Criterion for polynomial solutions to a class of linear differential equation of second order

We consider the differential equations y''=\lambda_0(x)y'+s_0(x)y, where \lambda_0(x), s_0(x) are C^{\infty}-functions. We prove (i) if the differential equation, has a polynomial solution of degree n >0, then \delta_n=\lambda_n s_{n-1}-\lambda_{n-1}s_n=0, where \lambda_{n}= \lambda_{n-1}^\prime+s_{n-1}+\lambda_0\lambda_{n-1}\hbox{and}\quad s_{n}=s_{n-1}^\prime+s_0\lambda_{k-1},\quad n=1,2,.... Conversely (ii) if \lambda_n\lambda_{n-1}\ne 0 and \delta_n=0, then the differential equation has a polynomial solution of degree at most n. We show that the classical differential equations of Laguerre, Hermite, Legendre, Jacobi, Chebyshev (first and second kind), Gegenbauer, and the Hypergeometric type, etc, obey this criterion. Further, we find the polynomial solutions for the generalized Hermite, Laguerre, Legendre and Chebyshev differential equations.Comment: 12 page

Perturbation theory in a framework of iteration methods

In a previous paper (J. Phys. A 36, 11807 (2003)), we introduced the `asymptotic iteration method' for solving second-order homogeneous linear differential equations. In this paper, we study perturbed problems in quantum mechanics and we use the method to find the coefficients in the perturbation series for the eigenvalues and eigenfunctions directly, without first solving the unperturbed problem.Comment: 13 page

Additional Quantitative Trait Loci and Candidate Genes for Seed Isoflavone Content in Soybean

Seed isoflavone content of soybean (Glycine max L. Merr.) is a trait of moderate heritablity and an ideal target for marker selection. To date over 20 QTL have been identified underlying this trait among seven populations. The objectives of this study were to identify additional QTL and candidate genes controlling isoflavone content in a set of recombinant inbred line (RIL) populations of soybean grown in two different seasons. Variations of isoflavones namely daidzein, glycitein and genistein contents over two growing seasons and locations suggests that isoflavones are influenced by both genes and environments. Six QTL were identified on five different chromosomes (Chr) or linkage groups (LG) that controlled daidzein (Chr_2/LG-M; Chr_17a/LG-D2), glycitein (Chr_2/LG-D1b; Chr_8/LG-A2) and genistein (Chr_8/LG-A2; Chr_12/LG-H) respectively in the seeds grown in season 2010. Two QTL were identified for daidzein (Chr_6/LG-C2; Chr_13b/LG-F), two QTLs for glycitein (Chr_1/LG-D1a; Chr_17c/LG-D2) and five QTLs for genistein (Chr_3/ LG-N; Chr_8/LG-A2; Chr_9/LG-K; Chr_18/LG-G) in the seeds of the 2011 growing season. Genes located within QTL confidence intervals were retrieved and gene ontology (GO) terms were used to identify those related to the flavonoid biosynthesis process. Twenty six candidate genes were identified that may be involved in isoflavones accumulation in soybean seeds

Sexual Functioning Among Endometrial Cancer Patients Treated With Adjuvant High-Dose-Rate Intra-Vaginal Radiation Therapy

Purpose—We used the Female Sexual Function Index (FSFI) to investigate the prevalence of sexual dysfunction (SD) and factors associated with diminished sexual functioning in early stage endometrial cancer (EC) patients treated with simple hysterectomy and adjuvant brachytherapy. Methods and Materials—A cohort of 104 patients followed in a radiation oncology clinic completed questionnaires to quantify current levels of sexual functioning. The time interval between hysterectomy and questionnaire completion ranged from 5 years. Multivariate regression was performed using the FSFI as a continuous variable (score range, 1.2–35.4). SD was defined as an FSFI score of <26, based on the published validation study. Results—SD was reported by 81% of respondents. The mean (±standard deviation) domain scores in order of highest-to-lowest functioning were: satisfaction, 2.9 (±2.0); orgasm, 2.5 (±2.4); desire, 2.4 (±1.3); arousal, 2.2 (±2.0); dryness, 2.1 (±2.1); and pain, 1.9 (±2.3). Compared to the index population in which the FSFI cut-score was validated (healthy women ages 18–74), all scores were low. Compared to published scores of a postmenopausal population, scores were not statistically different. Multivariate analysis isolated factors associated with lower FSFI scores, including having laparotomy as opposed to minimally invasive surgery (effect size, −7.1 points; 95% CI, −11.2 to −3.1; P<.001), lack of vaginal lubricant use (effect size, −4.4 points; 95% CI, −8.7 to −0.2, P = .040), and short time interval (<6 months) from hysterectomy to questionnaire completion (effect size, −4.6 points; 95% CI, −9.3–0.2; P = .059). Conclusions—The rate of SD, as defined by an FSFI score <26, was prevalent. The postmenopausal status of EC patients alone is a known risk factor for SD. Additional factors associated with poor sexual functioning following treatment for EC included receipt of laparotomy and lack of vaginal lubricant use

Increased levels of macrophage inflammatory proteins result in resistance to R5-tropic HIV-1 in a subset of elite controllers

Elite controllers (ECs) are a rare group of HIV seropositive individuals who are able to control viral replication without antiretroviral therapy. The mechanisms responsible for this phenotype, however, have not been fully elucidated. In this study, we examined CD4+ T cell resistance to HIV in a cohort of elite controllers and explored transcriptional signatures associated with cellular resistance. We demonstrate that a subgroup of elite controllers possess CD4+ T cells that are specifically resistant to R5-tropic HIV while remaining fully susceptible to X4-tropic and vesicular stomatitis virus G (VSV-G)-pseudotyped viruses. Transcriptome analysis revealed 17 genes that were differentially regulated in resistant elite controllers relative to healthy controls. Notably, the genes encoding macrophage inflammatory protein 1α (MIP-1α), CCL3 and CCL3L1, were found to be upregulated. The MIP-1α, MIP-1β, and RANTES chemokines are natural ligands of CCR5 and are known to interfere with HIV replication. For three elite controllers, we observed increased production of MIP-1α and/or MIP-1β at the protein level. The supernatant from resistant EC cells contained MIP-1α and MIP-1β and was sufficient to confer R5-tropic resistance to susceptible CD4+ T cells. Additionally, this effect was reversed by using inhibitory anti-MIP antibodies. These results suggest that the T cells of these particular elite controllers may be naturally resistant to HIV infection by blocking R5-tropic viral entr